Accuray Incorporated is expanding access to its products in the Middle East with the signing of an agreement with the Neuro Spinal Hospital (NSH) in Dubai, United Arab Emirates, for the acquisition of one CyberKnife M6 System and one Radixact System. The deal was entered into backlog during Accuray's fourth fiscal quarter, which ended June 30.
"We are very proud to be the first hospital in the Middle East to acquire the latest generation CyberKnife and Radixact Systems. We are building on our reputation as a leader in bringing the most advanced medical treatments to the community," said Prof. Abdul Karim Msaddi, Head of the Neurosurgery and Spine Department, Founder of Neuro Spinal Hospital, which will be named for the new hospital as the Neuro Spinal hospital and CyberKnife Center. "With these two leading-edge technologies in one location, we can expand our practice to offer personalized treatments to almost any patient who may benefit from radiation therapy."
CyberKnife M6 System Benefits
The CyberKnife M6 System will be primarily used by the hospital to treat neurological indications such as arteriovenous malformations and trigeminal neuralgia, and secondarily for extracranial cases such as prostate, lung and spine.
Radixact System Benefits
The Radixact System will be used to treat breast, head and neck, spine, as well as total marrow irradiation.
"We are pleased to work with Prof. Abdul Karim Msaddi and his team to bring our latest radiation therapy platforms to patients in Dubai and we are committed to supporting them in their goal to expand access to advanced radiotherapy," said Lionel Hadjadjeba, Senior Vice President, and Chief Commercial Officer at Accuray. "This new agreement with Neuro Spinal Hospital, a renowned neuroscience center of excellence, further demonstrates clinicians' confidence in the value of our Systems around the world."
Important Safety Information
For Important Safety Information please refer to http://www.accuray.com/safety-statement.
Dubai Neuro Spinal Hospital to acquire Accuray CyberKnife, Radixact systems . Appl Rad Oncol.